BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18328652)

  • 1. The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine.
    Shu H; Hayashida M; Huang W; An K; Chiba S; Hanaoka K; Arita H
    J Ethnopharmacol; 2008 Apr; 117(1):158-65. PubMed ID: 18328652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of morphine tolerance by processed Aconiti tuber is mediated by kappa-opioid receptors.
    Shu H; Arita H; Hayashida M; Chiba S; Sekiyama H; Hanaoka K
    J Ethnopharmacol; 2006 Jun; 106(2):263-71. PubMed ID: 16446067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of processed Aconiti tuber on the development of antinociceptive tolerance to morphine: evaluation with a thermal assay.
    Shu H; Hayashida M; Chiba S; Sekiyama H; Kitamura T; Yamada Y; Hanaoka K; Arita H
    J Ethnopharmacol; 2007 Sep; 113(3):560-3. PubMed ID: 17719732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of processed Aconiti tuber and its ingredient alkaloids on the development of antinociceptive tolerance to morphine.
    Shu H; Arita H; Hayashida M; Sekiyama H; Hanaoka K
    J Ethnopharmacol; 2006 Feb; 103(3):398-405. PubMed ID: 16169697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.
    Shu H; Hayashida M; Arita H; Huang W; Xiao L; Chiba S; Sekiyama H; Hanaoka K
    J Ethnopharmacol; 2008 Sep; 119(2):276-83. PubMed ID: 18687394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
    Elliott K; Minami N; Kolesnikov YA; Pasternak GW; Inturrisi CE
    Pain; 1994 Jan; 56(1):69-75. PubMed ID: 7512709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
    Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
    Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of processed Aconiti tuber on morphine-induced conditioned place preference in rats.
    Wu G; Huang W; Zhang H; Li Q; Zhou J; Shu H
    J Ethnopharmacol; 2011 Jun; 136(1):254-9. PubMed ID: 21549821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice.
    Kuzmin A; Sandin J; Terenius L; Ogren SO
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1031-42. PubMed ID: 11082438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice.
    Tsuji M; Yamazaki M; Takeda H; Matsumiya T; Nagase H; Tseng LF; Narita M; Suzuki T
    Eur J Pharmacol; 2000 Apr; 394(1):91-5. PubMed ID: 10771039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
    Kest B; McLemore G; Kao B; Inturrisi CE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development.
    Elliott K; Kest B; Man A; Kao B; Inturrisi CE
    Neuropsychopharmacology; 1995 Dec; 13(4):347-56. PubMed ID: 8747759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of kappa opioid receptors in formalin-induced inhibition of analgesic tolerance to morphine in mice.
    Tokuyama S; Nagae R; Mashida E; Hamabe W
    J Pharm Pharmacol; 2007 Aug; 59(8):1109-15. PubMed ID: 17725853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices.
    Lue WM; Su MT; Lin WB; Tao PL
    Eur J Pharmacol; 1999 Oct; 383(2):129-35. PubMed ID: 10585526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antagonism by MK-801 against antinociception induced by opioid receptor agonists administered supraspinally in mice.
    Suh HW; Song DK; Kim YH; Yoo JS; Tseng LF
    Eur J Pharmacol; 1994 Sep; 263(1-2):217-21. PubMed ID: 7821357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
    Bhargava HN; Thorat SN
    Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception.
    Kest B; Marek P; Liebeskind JC
    Brain Res; 1992 Aug; 589(1):139-42. PubMed ID: 1422813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.